Catherine J. Baker

Catherine J. Baker

Auto-generated profile, based on publicly available information

Catherine J. Baker

Affiliation Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
CBCatherine J. Baker
Catherine J. Baker
SSStephanie A. Smith
Stephanie A. Smith
James H. MorrisseyJames H. Morrissey
James H. Morrissey
This illustrated review focuses on polyphosphate as a potent modulator of the plasma clotting cascade, with possible roles in hemostasis, thrombosis, and inflammation. Polyphosphates are highly anionic, linear polymers of inorganic phosphates that are widespread throughout biology. Infectious microorganisms accumulate polyphosphates with widely varying polymer lengths (from a few phosphates to over a thousand phosphates long), while activated human platelets secrete polyphosphate with a very narrow size distribution (about 60‐100 phosphates long). Work from our lab and others has shown that long‐chain polyphosphate is a potent trigger of clotting via the contact pathway, while polyphosphate of the size secreted by platelets accelerates factor V activation, blocks the anticoagulant activity of tissue factor pathway inhibitor, promotes factor XI activation by thrombin, and makes fibrin fibrils thicker and more resistant to fibrinolysis. Polyphosphate also modulates inflammation by triggering bradykinin release, inhibiting the complement system, and modulating endothelial function. Polyphosphate and nucleic acids have similar physical properties and both will trigger the contact pathway—although polyphosphate is orders of magnitude more procoagulant than either DNA or RNA. Important caveats in these studies include observations that nucleic acids and polyphosphate may co‐purify, and that these preparations can be contaminated with highly procoagulant microparticles if silica‐based purification methods are employed. Polyphosphate has received attention as a possible therapeutic, with some recent studies exploring the use of polyphosphate in a variety of formulations to control bleeding. Other studies are investigating treatments that block polyphosphate function as novel antithrombotics with the possibility of reduced bleeding side effects.

7 July 2014 in Biomacromolecules
Verified
Journal Article
Open access
CHCarleigh F. F. Hebbard
Carleigh F. F. Hebbard
YWYan Wang
Yan Wang
CBCatherine J. Baker
Catherine J. Baker
James H. MorrisseyJames H. Morrissey
James H. Morrissey
Inorganic polyphosphates, linear polymers of orthophosphate, occur naturally throughout biology and have many industrial applications. Their biodegradable nature makes them attractive for a multitude of uses, and it would be important to understand how polyphosphates are turned over enzymatically. Studies of inorganic polyphosphatases are, however, hampered by the lack of high-throughput methods for detecting and quantifying rates of polyphosphate degradation. We now report chromogenic and fluorogenic polyphosphate substrates that permit spectrophotometric monitoring of polyphosphate hydrolysis and allow for high-throughput analyses of both endopolyphosphatase and exopolyphosphatase activities, depending on assay configuration. These substrates contain 4-nitrophenol or 4-methylumbelliferone moieties that are covalently attached to the terminal phosphates of polyphosphate via phosphoester linkages formed during reactions mediated by EDAC (1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide). This report identifies Nudt2 as an inorganic polyphosphatase and also adds to the known coupling chemistry for polyphosphates, permitting facile covalent linkage of alcohols with the terminal phosphates of inorganic polyphosphate.

6 July 2017 in Blood
Verified
Journal Article
Open access
PDF file
SSStephanie A. Smith
Stephanie A. Smith
CBCatherine J. Baker
Catherine J. Baker
JGJoshua M. Gajsiewicz
Joshua M. Gajsiewicz
James H. MorrisseyJames H. Morrissey
James H. Morrissey

9 April 2015 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
CCChristiane E. Carney
Christiane E. Carney
ILIvan Lenov
Ivan Lenov
CBCatherine J. Baker
Catherine J. Baker
KMKeith W. MacRenaris
Keith W. MacRenaris
AEAmanda L. Eckermann
Amanda L. Eckermann
Thomas MeadeThomas Meade
Thomas Meade

21 August 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CBCatherine J. Baker
Catherine J. Baker
SSStephanie A. Smith
Stephanie A. Smith
James H. MorrisseyJames H. Morrissey
James H. Morrissey
Investigation of the biological roles of inorganic polyphosphate has been facilitated by our previous development of a carbodiimide-based method for covalently coupling primary amine-containing molecules to the terminal phosphates of polyphosphate. We now extend that approach by optimizing the reaction conditions and using readily available “bridging molecules” containing a primary amine and an additional reactive moiety, including another primary amine, a thiol or a click chemistry reagent such as dibenzocyclooctyne. This two-step labeling method is used to covalently attach commercially available derivatives of biotin, peptide epitope tags, and fluorescent dyes to the terminal phosphates of polyphosphate. Additionally, we report three facile methods for purifying conjugated polyphosphate from excess reactants.